iTeos Therapeutics, Inc. (ITOS)

iTeos Therapeutics Revenue

iTeos Therapeutics had revenue of $35.00M in the twelve months ending March 31, 2025. In the year 2024, iTeos Therapeutics had annual revenue of $35.00M with 177.89% growth.

• Revenue (ttm): $35.00M
• Revenue Growth: +177.89%
• P/S Ratio: 12.47
• Revenue / Employee: $202,312
• Employees: 173
• Market Cap: 395.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	35.00M	22.41M	177.89%
Dec 31, 2023	12.60M	-255.04M	-95.29%
Dec 31, 2022	267.63M	-77.15M	-22.38%
Dec 31, 2021	344.78M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.